首页> 美国卫生研究院文献>other >National Cancer Institute Pediatric Preclinical Testing Program: Model Description for In Vitro Cytotoxicity Testing

【2h】

National Cancer Institute Pediatric Preclinical Testing Program: Model Description for In Vitro Cytotoxicity Testing

机译：国家癌症研究所小儿临床前测试程序：体外细胞毒性测试的模型描述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe National Cancer Institute (NCI) has established the Pediatric Preclinical Testing Program (PPTP) for testing drugs against in vitro and in vivo childhood cancer models to aid in the prioritization of drugs considered for early phase pediatric clinical trials.

著录项

期刊名称 other
作者
Min H. Kang; Malcolm A. Smith; Christopher L. Morton; Nino Keshelava; Peter J. Houghton; C. Patrick Reynolds;
展开▼
作者单位

展开▼
年(卷),期 -1(56),2
年度 -1
页码 239–249
总页数 20
原文格式 PDF
正文语种
中图分类
关键词
Cell line models childhood cancer cytotoxicity DIMSCAN NCI PPTP;

机译：细胞系模型;儿童期癌症;细胞毒性;DIMSCAN;NCI PPTP;

相似文献

外文文献
中文文献
专利

1. National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing. [J] . Kang MH, Smith MA, Morton CL, Pediatric blood & cancer . 2011,第2期

机译：美国国家癌症研究所儿科临床前测试程序：用于体外细胞毒性测试的模型描述。
2. The pediatric preclinical testing program: description of models and early testing results. [J] . Houghton PJ, Morton CL, Tucker C, Pediatric blood & cancer . 2007,第7期

机译：儿科临床前测试程序：模型说明和早期测试结果。
3. Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program [J] . MortonC.L., MarisJ.M., KeirS.T., Pediatric blood & cancer . 2012,第4期

机译：儿科临床前测试程序对西地那尼（AZD2171）对儿童癌症模型的组合测试
4. Development of a tumour model for preclinical tests of targeted anticancer drug formulationsbased on Caco-2 cells grown on the chicken embryos chorioallantoic membrane (CAM) [C] . Brigitta Loretz, Ulrich F. Schaefer, Claus-Michael Lehr Annual meeting exposition of the Controlled Release Society . 2009

机译：基于在鸡胚绒膜尿囊膜（CAM）上生长的Caco-2细胞的靶向抗癌药物制剂的临床前测试肿瘤模型的开发
5. Dichloro (4, 4'-bis (4, 4, 4-trifluorobutyl)-2, 2'-bipyridine1 platinum, a novel cisplatin analog, exhibits enhanced anticancer activity in preclinical models of Upper Gastrointestinal Cancers. [D] . Bapat, Samhita G. 2016

机译：二氯（4，4'-双（4，4，4-三氟丁基）-2，2'-联吡啶1铂，一种新型的顺铂类似物，在上消化道癌的临床前模型中表现出增强的抗癌活性。
6. Combination Testing of Cediranib (AZD2171) against Childhood Cancer Models by the Pediatric Preclinical Testing Program [O] . Christopher L. Morton, John M. Maris, Stephen T. Keir, -1

机译：儿科临床前测试计划对儿童癌模型进行Cediranib（AZD2171）的组合测试
7. National Cancer Institute pediatric preclinical testing program: Model description for in vitro cytotoxicity testing [O] . Min H. Kang, Malcolm A. Smith, Christopher L. Morton, 2010

机译：国家癌症研究所小儿临床前测试程序：体外细胞毒性测试的模型描述
8. NCI/TPO (National Cancer Institute/Toxicology Program Office) Synopsis. Preclinical Evaluation of Triazine Antifol (NSC-127755) [R] . 1985

机译：NCI / TpO（国家癌症研究所/毒理学计划办公室）简介。三嗪antifol的临床前评估（NsC-127755）

National Cancer Institute Pediatric Preclinical Testing Program: Model Description for In Vitro Cytotoxicity Testing

摘要

著录项

相似文献

相关主题

期刊订阅